By: Jill Murphy, Assistant Editor From: pharmacytimes.com Approximately 1 in 40 postmenopausal women diagnosed with breast cancer before the age of 65 had a mutation linked to cancer in the BRCA1 or BRCA2 gene, according to an analysis of data from the Women’s Health Initiative (WHI). This finding suggests that genetic testing may be beneficial for postmenopausal women who are …